MEDIROM MOTHER Labs Inc. Receives Capital Investment from Internal Investors

Core Viewpoint - MEDIROM MOTHER Labs has completed a private placement of new shares valued at ¥9 billion as part of its Series A funding round, involving key management members as investors to enhance business responsibility and growth motivation [1][2]. Group 1: Company Overview - MEDIROM MOTHER Labs is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on health tech, specifically through the "Lav" healthcare app and the "MOTHER Bracelet" wearable device [5]. - The company aims to provide customizable health management solutions across various sectors, including caregiving, logistics, and manufacturing [5]. Group 2: Business Strategy - The completion of the capital increase will strengthen MEDIROM MOTHER Labs' capital base, enabling accelerated development of upgraded versions of the "MOTHER Bracelet" and the establishment of systems for launching new products [3]. - The management team becoming investors is intended to enhance swift decision-making and a field-driven management structure, thereby increasing business responsibility [2]. Group 3: Future Outlook - MEDIROM MOTHER Labs plans to deliver new value in the healthcare and wellness field, driving sustainable growth both domestically and internationally [3].